Ronald Acuña Jr.’s return helped solidify the Braves’ outfield, but Atlanta still faces lingering lineup issues. In fact, their toughest roster decision might still be ahead — one that could significantly impact their season trajectory.
Jurickson Profar isn’t winning over many fans in the South right now. He was the Braves’ only notable free-agent acquisition this offseason, but after just four games, a positive PED test sidelined him. That setback left Atlanta scrambling, rotating players like Jarred Kelenic, Bryan De La Cruz, Alex Verdugo, Eli White, and Stuart Fairchild in an effort to stay competitive.
Despite those challenges, the Braves held their ground reasonably well until Acuña returned, though they still trail the surging Phillies by 8.5 games in the NL East. Now, a critical decision looms: Profar is about a month from returning — and just weeks away from a rehab stint — putting pressure on the Braves to choose between immediate impact and long-term growth.
How should the Braves handle Jurickson Profar’s return from suspension?
Serving an 80-game suspension was already a major setback for Jurickson Profar, but the bigger blow is that he’ll be ineligible for the postseason — no matter how well he plays upon his return. After missing three months, there are questions about how sharp he’ll be and whether his impressive 2024 performance was fueled by more than just talent. Still, given the Braves’ current instability in left field, it’s hard to argue he wouldn’t be their best option down the stretch.
But at what long-term cost? Is it wise for Atlanta to prioritize their strongest possible lineup during July, August, and September, knowing Profar can’t contribute in October? Or should that playing time be used to develop a more sustainable solution in left field — someone who could help if the Braves do make the postseason?
Profar will undoubtedly be given a chance to earn his spot. If he picks up where he left off with the Padres, this debate may become irrelevant. After all, a team has to make the playoffs before worrying about how to win in them. With this core group still in its competitive window, the Braves can’t afford to overthink. But if they climb back into the NL East or Wild Card race, the front office will have to carefully navigate the tension between short-term performance and long-term viability.
Leave a Reply